BLOG

Monday, April 1, 2019

Cipla gets 8 observations from USFDA for Kurkumbh plant in Maharashtra

The company has also received 10 observations pertaining to a product specific pre-approval (PAI) from the same plant, Cipla said in a BSE filing.

from Companies https://ift.tt/2uEeXgS
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...